"The U.S. Food and Drug Administration today expanded the approved use of Opdivo (nivolumab) to treat patients with advanced (metastatic) squamous non-small cell lung cancer (NSCLC) with progression on or after platinum-based chemotherapy.
Thiotepa Patient Information including How Should I Take
In this Article
- What is thiotepa (Thiotepa)?
- What are the possible side effects of thiotepa (Thiotepa)?
- What is the most important information I should know about thiotepa (Thiotepa)?
- What should I discuss with my healthcare provider before receiving thiotepa (Thiotepa)?
- How is thiotepa given (Thiotepa)?
- What happens if I miss a dose (Thiotepa)?
- What happens if I overdose (Thiotepa)?
- What should I avoid while receiving thiotepa (Thiotepa)?
- What other drugs will affect thiotepa (Thiotepa)?
- Where can I get more information?
What should I discuss with my healthcare provider before receiving thiotepa (Thiotepa)?
You should not receive thiotepa if you are allergic to it.
To make sure you can safely receive thiotepa, tell your doctor if you have any of these other conditions:
- kidney disease;
- liver disease; or
- bone marrow suppression.
Tell your doctor about all other cancer treatments you have recently received, including chemotherapy and radiation.
FDA pregnancy category D. Do not use thiotepa if you are pregnant. It could harm the unborn baby. Use effective birth control, and tell your doctor if you become pregnant during treatment.
Use birth control to prevent pregnancy while you are receiving thiotepa, whether you are a man or a woman. Thiotepa use by either parent may cause birth defects.
It is not known whether thiotepa passes into breast milk or if it could harm a nursing baby. You should not breast-feed while you are using thiotepa.
How is thiotepa given (Thiotepa)?
Thiotepa is injected into a vein through an IV, or injected directly into the bladder or other body cavity. You will receive this injection in a clinic or hospital setting.
When injected into the bladder, you will need to hold the medicine inside your bladder for 2 hours. Tell your caregivers if this causes you a great deal of discomfort. You may need to receive a smaller amount of the medicine to hold it comfortably in your bladder.
If any of this medication accidentally gets on your skin, wash it thoroughly with soap and warm water.
Thiotepa is usually given once every 1 to 4 weeks. Follow your doctor's dosing instructions very carefully.
Thiotepa can lower blood cells that help your body fight infections and help your blood to clot. Your blood will need to be tested often during treatment and for at least 3 weeks after you stop receiving thiotepa. Your cancer treatments may be delayed based on the results of these tests. Visit your doctor regularly.
Additional Thiotepa Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.